JP2011516606A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011516606A5 JP2011516606A5 JP2011504940A JP2011504940A JP2011516606A5 JP 2011516606 A5 JP2011516606 A5 JP 2011516606A5 JP 2011504940 A JP2011504940 A JP 2011504940A JP 2011504940 A JP2011504940 A JP 2011504940A JP 2011516606 A5 JP2011516606 A5 JP 2011516606A5
- Authority
- JP
- Japan
- Prior art keywords
- progesterone
- pharmaceutical composition
- aqueous suspension
- specific geometric
- injectable aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 10
- 229960003387 progesterone Drugs 0.000 claims 5
- 239000000186 progesterone Substances 0.000 claims 5
- 239000002245 particle Substances 0.000 claims 4
- 239000007900 aqueous suspension Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 239000013078 crystal Substances 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/MX2008/000051 WO2009128692A1 (es) | 2008-04-14 | 2008-04-14 | Método y composición farmacéutica para lograr niveles plasmáticos de progesterona requeridos para diferentes indicaciones terapéuticas |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011516606A JP2011516606A (ja) | 2011-05-26 |
| JP2011516606A5 true JP2011516606A5 (enExample) | 2012-04-12 |
Family
ID=41199287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011504940A Pending JP2011516606A (ja) | 2008-04-14 | 2008-04-14 | 様々な治療指標に必要な血漿プロゲステロン濃度を得るための方法および医薬組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20110104289A1 (enExample) |
| EP (1) | EP2272519A4 (enExample) |
| JP (1) | JP2011516606A (enExample) |
| CN (1) | CN102056611A (enExample) |
| BR (1) | BRPI0822165A2 (enExample) |
| CA (1) | CA2721509A1 (enExample) |
| IL (1) | IL208723A0 (enExample) |
| WO (1) | WO2009128692A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014012444B1 (pt) | 2011-11-23 | 2021-12-14 | Therapeuticsmd, Inc | Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
| AU2015296609A1 (en) | 2014-07-29 | 2016-12-22 | Therapeuticsmd, Inc. | Transdermal cream |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| WO2019086410A1 (en) * | 2017-10-30 | 2019-05-09 | Carmentix Pte. Ltd. | Biomarkers of preterm birth |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2663224B1 (fr) | 1990-06-14 | 1995-01-20 | Applicationes Farmaceuticas Sa | Forme galenique parenterale. |
| FR2663223B1 (fr) * | 1990-06-14 | 1994-12-02 | Af Aplicaciones Far Lab | Forme galenique parenterale. |
| JPH0474117A (ja) * | 1990-07-16 | 1992-03-09 | Kokuritsu Eisei Shikenjo | 新規なマイクロスフェア |
| US6287693B1 (en) * | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
| US6544553B1 (en) * | 1999-12-28 | 2003-04-08 | Watson Pharmaceuticals, Inc. | Dosage forms and methods for oral delivery of progesterone |
| ATE454885T1 (de) * | 2003-06-13 | 2010-01-15 | Skendi Finance Ltd | Mikrosphären von estradiol und cholesterol |
-
2008
- 2008-04-14 US US12/937,779 patent/US20110104289A1/en not_active Abandoned
- 2008-04-14 CN CN2008801294325A patent/CN102056611A/zh active Pending
- 2008-04-14 EP EP08741598A patent/EP2272519A4/en not_active Withdrawn
- 2008-04-14 WO PCT/MX2008/000051 patent/WO2009128692A1/es not_active Ceased
- 2008-04-14 BR BRPI0822165-0A patent/BRPI0822165A2/pt not_active IP Right Cessation
- 2008-04-14 JP JP2011504940A patent/JP2011516606A/ja active Pending
- 2008-04-14 CA CA2721509A patent/CA2721509A1/en not_active Abandoned
-
2010
- 2010-10-14 IL IL208723A patent/IL208723A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011516606A5 (enExample) | ||
| JP2013533128A5 (enExample) | ||
| MX2011011230A (es) | Produccion de nanoparticulas encapsuladas en fracciones de alto volumen. | |
| JP2012144538A5 (enExample) | ||
| IL217717A (en) | History of Acids (3,1-Thiazole-4-Yl) Carbonylamono-Alkanes | |
| JP2011078421A5 (enExample) | ||
| JP2013540852A5 (enExample) | ||
| JP2010539123A5 (enExample) | ||
| WO2009092129A8 (en) | Delayed release pharmaceutical composition of duloxetine | |
| IL208851A0 (en) | Process for the production of particles comprising active agrochemical ingredients in amorphous form | |
| JP2013230157A5 (enExample) | ||
| Kim et al. | Boundary Harnack principle for subordinate Brownian motions | |
| JP2010281322A5 (enExample) | ||
| WO2010132047A8 (en) | Guanosine/gmp gels and uses thereof | |
| JP2008280345A5 (enExample) | ||
| AR090725A1 (es) | Metodos para producir clorhidrato de anamorelina que tiene contenido controlado de cloruro | |
| JP2014166710A5 (enExample) | ||
| CO6970124A1 (es) | Composición farmacéutica en forma de una suspensión oral que comprende una fracción flavonoica y goma de xantano | |
| JP2012532753A5 (enExample) | ||
| JP2012030220A5 (ja) | 極小径粒の作製方法および正極活物質の作製方法 | |
| BRPI1006471A2 (pt) | composição aquosa, para processo para a preparação de uma composição, uso de sal para desacelarar o crescimento da particula em uma composição aquosa, uso da composição e semente | |
| JP2010030903A5 (enExample) | ||
| NZ710321A (en) | Production of encapsulated nanoparticles at high volume fractions | |
| RU2007125820A (ru) | Способ получения биологически активной добавки | |
| TH96946B (th) | ของเล่น |